rs10800597
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000436880.2(MIR181A1HG):n.1819C>T variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.724 in 151,930 control chromosomes in the GnomAD database, including 40,351 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.72 ( 40351 hom., cov: 32)
Failed GnomAD Quality Control
Consequence
MIR181A1HG
ENST00000436880.2 non_coding_transcript_exon
ENST00000436880.2 non_coding_transcript_exon
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.819
Genes affected
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 1-198898955-G-A is Benign according to our data. Variant chr1-198898955-G-A is described in ClinVar as [Benign]. Clinvar id is 427755.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.852 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MIR181A1HG | NR_040073.1 | n.363+1456C>T | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MIR181A1HG | ENST00000436880.2 | n.1819C>T | non_coding_transcript_exon_variant | 2/2 | 1 | |||||
MIR181A1HG | ENST00000665868.2 | n.1861C>T | non_coding_transcript_exon_variant | 2/2 | ||||||
MIR181A1HG | ENST00000432296.1 | n.344+1456C>T | intron_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.724 AC: 109963AN: 151812Hom.: 40313 Cov.: 32
GnomAD3 genomes
AF:
AC:
109963
AN:
151812
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AC0AC: 0AN: 0Hom.: 0 Cov.: 0AC XY: 0AN XY: 0
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AC:
0
AN:
0
Hom.:
Cov.:
0
AC XY:
0
AN XY:
0
GnomAD4 genome AF: 0.724 AC: 110059AN: 151930Hom.: 40351 Cov.: 32 AF XY: 0.730 AC XY: 54176AN XY: 74210
GnomAD4 genome
AF:
AC:
110059
AN:
151930
Hom.:
Cov.:
32
AF XY:
AC XY:
54176
AN XY:
74210
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2884
AN:
3470
ClinVar
Significance: Benign
Submissions summary: Pathogenic:1Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Acute myeloblastic leukemia with maturation Pathogenic:1
Pathogenic, no assertion criteria provided | case-control | Fujian Institute of Hematology, Fujian Medical University | - | This variant contributes to development of AML-M2 - |
not specified Benign:1
Benign, criteria provided, single submitter | research | H3Africa Consortium | Oct 28, 2020 | While the frequency of the alternate allele in gnoMAD v2.0.2 is 0.875, its frequency in African populations is >5%. This suggests that previous classifications of this variant as pathogenic are in error. - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at